| [1] |
Wang JN， Zheng G， Wu W，et al.Follicular helper T cells：emerging roles in lymphomagenesis[J]． J Leukoc Biol， 2024， 116(1)：54-63.DOI： 10.1093/jleuko/qiad140.
|
| [2] |
Jain S，Mallick S，Ramteke P，et al.Neoplasms of follicular helper T-cells：an insight into the pathobiology [J]．Am J Blood Res，2022，12(3)：64-81.
|
| [3] |
Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5，localize to B cell follicles，and support immunoglobulin production[J]． J Exp Med， 2000， 192(11)：1545-1552.DOI： 10.1084/jem.192.11.1545.
|
| [4] |
Choi YS， Kageyama R， Eto D，et al.ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6[J]． Immunity， 2011， 34(6)：932-946.DOI： 10.1016/j.immuni.2011.03.023.
|
| [5] |
Yu D, Rao S, Tsai LM, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment [J]． Immunity， 2009， 31(3)：457-468.DOI： 10.1016/j.immuni.2009.07.002.
|
| [6] |
Schmitt N， Bentebibel SE， Ueno H．Phenotype and functions of memory Tfh cells in human blood[J]． Trends Immunol， 2014， 35(9)：436-442.DOI： 10.1016/j.it.2014.06.002.
|
| [7] |
Rodriguez S， Alizadeh M， Lamaison C，et al.Follicular lymphoma regulatory T-cell origin and function[J]． Front Immunol， 2024(15)：1391404.DOI： 10.3389/fimmu.2024.1391404.
|
| [8] |
Ding BB, Bi E, Chen H, et al. IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells[J]． J Immunol， 2013， 190(4)：1827-1836.DOI： 10.4049/jimmunol.1201678.
|
| [9] |
Shi J， Hou S， Fang Q，et al.PD-1 controls follicular T helper cell positioning and function[J]． Immunity， 2018， 49(2)：264-274.e4.DOI： 10.1016/j.immuni.2018.06.012.
|
| [10] |
Wu H， Deng Y， Zhao M，et al.Molecular control of follicular helper T cell development and differentiation[J]． Front Immunol， 2018(9)：2470.DOI： 10.3389/fimmu.2018.02470.
|
| [11] |
Chiba S, Sakata-Yanagimoto M. Advances in understanding of angioimmunoblastic T-cell lymphoma[J]． Leukemia， 2020， 34(10)：2592-2606.DOI： 10.1038/s41375-020-0990-y.
|
| [12] |
Fujisawa M， Sakata-Yanagimoto M， Nishizawa S，et al.Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma[J]． Leukemia， 2018， 32(3)：694-702.DOI： 10.1038/leu.2017.273.
|
| [13] |
Ng SY, Brown L, Stevenson K, et al. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice[J]． Blood， 2018， 132(9)：935-947.DOI： 10.1182/blood-2017-11-818617.
|
| [14] |
Jacobsen E．Follicular lymphoma：2023 update on diagnosis and management[J]． Am J Hematol， 2022， 97(12)：1638-1651.DOI： 10.1002/ajh.26737.
|
| [15] |
Laurent C， Dietrich S， Tarte K．Cell cross talk within lymphoma tumor microenvironment：follicular lymphoma as a Paradigm [J]． Blood， 2024， 143(12)：1080-1090.DOI： 10.1182/blood.2023021000.
|
| [16] |
El Daker S， Qualls D， Derkach A，et al.Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment[J]． Haematologica， 2025， 110(8)：1808-1821.DOI： 10.3324/haematol.2024.286383.
|
| [17] |
Haebe S， Shree T， Sathe A，et al.Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma[J]． Blood， 2021， 137(21)：2869-2880.DOI： 10.1182/blood.2020009855.
|
| [18] |
Fanale M， Assouline S， Kuruvilla J，et al.Phase IA/II，multicentre，open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma[J]． Br J Haematol， 2014， 164(2)：258-265.DOI： 10.1111/bjh.12630.
|
| [19] |
Pangault C， Amé-Thomas P， Ruminy P，et al.Follicular Lymphoma cell niche：identification of a preeminent IL-4-dependent T(FH)-B cell axis [J]． Leukemia， 2010， 24(12)：2080-2089.DOI： 10.1038/leu.2010.223.
|
| [20] |
Mentz M， Keay W， Strobl CD，et al.PARP14 is a novel target in STAT6 mutant follicular lymphoma[J]． Leukemia， 2022， 36(9)：2281-2292.DOI： 10.1038/s41375-022-01641-x.
|
| [21] |
Mintz MA， Cyster JG.T follicular helper cells in germinal center B cell selection and lymphomagenesis[J]． Immunol Rev， 2020， 296(1)：48-61.DOI： 10.1111/imr.12860.
|
| [22] |
Cha Z， Guo H， Tu X，et al.Alterations of circulating follicular helper T cells and interleukin 21 in diffuse large B-cell lymphoma[J]． Tumour Biol， 2014， 35(8)：7541-7546.DOI： 10.1007/s13277-014-1999-5.
|
| [23] |
Ma X， Zha J， He J，et al.T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients[J]． Hum Immunol， 2020， 81(8)：452-459.DOI： 10.1016/j.humimm.2020.05.008.
|
| [24] |
Cha Z， Qian G， Zang Y，et al.Circulating CXCR5＋CD4＋ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway[J]． Exp Cell Res， 2017， 350(1)：154-160.DOI： 10.1016/j.yexcr.2016.11.017.
|
| [25] |
Wen J， Nie X， Zhou Q，et al.Elevated serum IL-10/IL-6 ratio as a novel biomarker for secondary central nervous system lymphoma and poor prognosis in DLBCL[J]． Front Immunol， 2025(16)：1656044.DOI： 10.3389/fimmu.2025.1656044.
|
| [26] |
Mintz MA， Felce JH， Chou MY，et al. The HVEM-BTLA axis restrains T cell help to germinal center B cells and functions as a cell-extrinsic suppressor in lymphomagenesis[J]． Immunity， 2019， 51(2)：310-323.e7.DOI： 10.1016/j.immuni.2019.05.022.
|
| [27] |
Manso BA, Wenzl K, Asmann YW, et al. Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma[J]． Blood Cancer J， 2017， 7(4)：e553.DOI： 10.1038/bcj.2017.33.
|
| [28] |
de Weerdt I， Hofland T， de Boer R，et al.Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment[J]． Blood Adv， 2019， 3(17)：2642-2652.DOI： 10.1182/bloodadvances.2019000360.
|
| [29] |
Wu X， Fajardo-Despaigne JE， Zhang C，et al.Altered T follicular helper cell subsets and function in chronic lymphocytic leukemia[J]． Front Oncol， 2021(11)：674492.DOI： 10.3389/fonc.2021.674492.
|
| [30] |
Le Saos-Patrinos C, Loizon S, Zouine A, et al. Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion[J]． J Leukoc Biol， 2023， 113(3)：305-314.DOI： 10.1093/jleuko/qiad006.
|
| [31] |
Cha Z， Zang Y， Guo H，et al.Association of peripheral CD4＋ CXCR5＋ T cells with chronic lymphocytic leukemia[J]． Tumour Biol， 2013， 34(6)：3579-3585.DOI： 10.1007/s13277-013-0937-2.
|
| [32] |
Bürkle A， Niedermeier M， Schmitt-Gräff A，et al.Overexpression of the CXCR5 chemokine receptor，and its ligand，CXCL13 in B-cell chronic lymphocytic leukemia[J]． Blood， 2007， 110(9)：3316-3325.DOI： 10.1182/blood-2007-05-089409.
|
| [33] |
Heinig K， Gätjen M， Grau M，et al.Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation[J]． Cancer Discov， 2014， 4(12)：1448-1465.DOI： 10.1158/2159-8290.CD-14-0096.
|
| [34] |
Zhang R， Guo S， Qu J．Exploring the prognostic value of T follicular helper cell levels in chronic lymphocytic leukemia[J]． Sci Rep， 2024， 14(1)：22443.DOI： 10.1038/s41598-024-73325-8.
|
| [35] |
Yano M, Sharpe C, Lance JR, et al. Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy[J]． Blood Adv， 2022， 6(20)：5641-5654.DOI： 10.1182/bloodadvances.2021005883.
|
| [36] |
Bunse M, Pfeilschifter J, Bluhm J, et al. CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin's lymphoma and tumor-supportive follicular T helper cells[J]． Nat Commun， 2021， 12(1)：240.DOI： 10.1038/s41467-020-20488-3.
|
| [37] |
Abdel-Rahman SA, Świderek K, Gabr MT. First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators[J]． RSC Med Chem， 2023， 14(9)：1767-1777.DOI： 10.1039/d3md00150d.
|
| [38] |
Boice M， Salloum D， Mourcin F，et al.Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T dells[J]． Cell， 2016， 167(2)：405-418.e13.DOI： 10.1016/j.cell.2016.08.032.
|
| [39] |
Li C， Zhang L， Jin Q，et al.Role and application of chemokine CXCL13 in central nervous system lymphoma[J]． Ann Hematol， 2024， 103(8)：2671-2680.DOI： 10.1007/s00277-023-05560-4.
|